GW Pharmaceuticals - 6 Year Stock Price History | GWPH

Historical daily share price chart and data for GW Pharmaceuticals since 2013 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for GW Pharmaceuticals as of February 15, 2019 is 150.49.
GW Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 134.0119 101.0100 151.2900 99.6900 150.4900 54.52%
2018 135.9010 134.0900 174.5000 94.3600 97.3900 -26.23%
2017 113.6863 112.3800 138.7600 94.1400 132.0100 18.13%
2016 89.0206 68.4600 134.0200 36.6400 111.7500 60.93%
2015 96.9463 70.0400 129.6900 64.9600 69.4400 2.60%
2014 72.8060 40.5800 107.3500 38.0600 67.6800 62.93%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.563B $0.013B
GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.916B 25.68
Medtronic (MDT) Ireland $122.526B 18.32
Stryker (SYK) United States $69.144B 25.38
Boston Scientific (BSX) United States $55.241B 26.97
Baxter (BAX) United States $38.548B 23.75
Zimmer Biomet Holdings (ZBH) United States $24.985B 16.03
Smith & Nephew SNATS (SNN) United Kingdom $16.606B 0.00
ResMed (RMD) United States $14.250B 27.02
Canopy Growth (CGC) Canada $10.707B 0.00
Bio-Rad Laboratories (BIO) United States $7.832B 50.08
Aurora Cannabis (ACB) Canada $7.090B 50.71
Hill-Rom Holdings (HRC) United States $6.904B 21.35
Perrigo (PRGO) Ireland $6.603B 10.02
ICU Medical (ICUI) United States $5.119B 28.52
Insulet (PODD) United States $5.012B 0.00
Haemonetics (HAE) United States $4.395B 38.99
Agios Pharmaceuticals (AGIO) United States $3.341B 0.00
Hutchison China MediTech (HCM) China $3.330B 0.00
Neogen (NEOG) United States $3.259B 50.06
NuVasive (NUVA) United States $3.008B 27.99
National Vision Holdings (EYE) United States $2.570B 49.72
Quidel (QDEL) United States $2.529B 22.88
Aphria (APHA) $2.274B 101.00
NxStage Medical (NXTM) United States $1.945B 0.00
AtriCure (ATRC) United States $1.269B 0.00
VAREX IMAGING (VREX) United States $1.196B 23.42
Phibro Animal Health (PAHC) United States $1.192B 17.13
Cardiovascular Systems (CSII) United States $1.151B 826.00
HEXO (HEXO) $1.127B 0.00
MacroGenics (MGNX) United States $0.893B 0.00
Cerus (CERS) United States $0.848B 0.00
PetIQ (PETQ) United States $0.821B 21.28
Evolus (EOLS) United States $0.744B 0.00
Surmodics (SRDX) United States $0.724B 105.35
NanoString Technologies (NSTG) United States $0.721B 0.00
Lantheus Holdings (LNTH) United States $0.711B 22.00
OraSure Technologies (OSUR) United States $0.707B 31.19
Omeros (OMER) United States $0.703B 0.00
Meridian Bioscience (VIVO) United States $0.698B 20.80
Eagle Pharmaceuticals (EGRX) United States $0.604B 19.39
Quanterix (QTRX) United States $0.491B 0.00
LeMaitre Vascular (LMAT) United States $0.486B 23.89
Owens & Minor (OMI) United States $0.470B 5.32
TG Therapeutics (TGTX) United States $0.390B 0.00
Insys Therapeutics (INSY) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.98
BioLife Solutions (BLFS) United States $0.285B 385.00
Bovie Medical (APYX) United States $0.283B 0.00
Vapotherm (VAPO) United States $0.279B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.272B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.228B 0.00
Zynex (ZYXI) United States $0.165B 15.97
Surface Oncology (SURF) United States $0.152B 0.00
Fonar (FONR) United States $0.147B 7.87
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.11
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.079B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.53
Conatus Pharmaceuticals (CNAT) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.033B 0.00
Senestech (SNES) United States $0.020B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14